Enter your credentials to acces your account.
PT-141, also known as Bremelanotide, is a synthetic peptide derived from melanocortin peptides and is primarily studied for its interaction with the central nervous system, rather than peripheral vascular pathways. Unlike some peptides that exert effects via hormonal or circulatory mechanisms, PT-141 is notable for its direct action on melanocortin receptors within the brain.
This unique mechanism has made PT-141 a subject of ongoing research into neuroendocrine signalling, behavioural biology, and central receptor activation, positioning it as a distinct compound within peptide research.
PT-141 belongs to the melanocortin peptide family and is structurally related to α-MSH (alpha-melanocyte-stimulating hormone). Research interest in PT-141 centres on its ability to bind selectively to melanocortin receptors (particularly MC3R and MC4R), which are involved in a range of neurological and physiological regulatory processes.
Importantly, PT-141 does not rely on nitric oxide pathways, distinguishing it from compounds studied primarily for vascular effects and making it relevant in studies focused on central nervous system activity.
PT-141 is believed to exert its effects by activating melanocortin receptors in the hypothalamus and other regions of the brain. These receptors play a role in regulating behaviour, motivation, and neuroendocrine signalling.
By acting centrally rather than peripherally, PT-141 provides researchers with a tool for investigating brain-mediated signalling pathways and receptor-specific responses, particularly within the melanocortin system.
Neuroendocrine Signalling Research
PT-141 is commonly studied in laboratory settings to better understand how melanocortin receptors influence neuroendocrine communication and central regulatory mechanisms.
Behavioural and Neurological Studies
Due to its central receptor activity, PT-141 is of interest in research examining behavioural modulation, motivation pathways, and neurological response patterns.
Melanocortin Receptor Function
PT-141 serves as a valuable research compound for exploring MC3R and MC4R receptor dynamics, receptor binding specificity, and downstream signalling effects.
Comparative Pathway Analysis
Researchers often compare PT-141 with other peptides that act via peripheral pathways to better understand the differences between central and systemic peptide activity.
Current research into PT-141 is largely experimental and academic, with studies focused on receptor pharmacology, CNS signalling, and melanocortin system mapping. While published literature exists, continued investigation is required to further clarify its broader biological implications.
PT-141 remains a specialist research peptide, valued primarily for its central mechanism of action rather than systemic hormonal effects.
Store lyophilised peptide at –20 °C.
Aliquot after reconstitution to avoid repeated freeze–thaw cycles.
Reconstituted peptide may be stored at 4 °C for a limited period.
When stored correctly, the lyophilised product remains stable until the stated expiry date.
Source: Biosynthesis
Reconstitution: Reconstitute with Bacteriostatic Water
Product is prepared for LABORATORY RESEARCH ONLY.
PT-141 for sale at Pure Peptides UK is limited to scientific research and educational use only.
Only purchase PT-141 if you are a licenced researcher.
PT-141 10 mg (Bremelanotide) is a centrally acting research peptide distinguished by its interaction with melanocortin receptors in the brain. Its unique mechanism makes it a valuable compound for studies into neuroendocrine signalling, receptor pharmacology, and CNS-mediated biological processes. As research progresses, PT-141 continues to contribute to a deeper understanding of melanocortin system function.
| Weight | 6 g |
|---|---|
| Cap Colour | Blue |
